These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17080116)

  • 1. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy.
    Davies SJ
    Kidney Int Suppl; 2006 Nov; (103):S76-83. PubMed ID: 17080116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
    Davies SJ
    Kidney Int; 2004 Dec; 66(6):2437-45. PubMed ID: 15569337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.
    Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC;
    Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Method to Increase Ultrafiltration in Peritoneal Dialysis: Steady Concentration Peritoneal Dialysis.
    Pérez-Díaz V; Pérez-Escudero A; Sanz-Ballesteros S; Rodríguez-Portela G; Valenciano-Martínez S; Palomo-Aparicio S; Hernández-García E; Sánchez-García L; Gordillo-Martín R; Marcos-Sánchez H
    Perit Dial Int; 2016 9-10; 36(5):555-61. PubMed ID: 27282854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
    Freida P; Galach M; Divino Filho JC; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(3):267-76. PubMed ID: 17468474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Large Intraperitoneal Residual Volume Hampers Adequate Volumetric Assessment of Osmotic Conductance to Glucose.
    Clause AL; Keddar M; Crott R; Darius T; Fillee C; Goffin E; Morelle J
    Perit Dial Int; 2018; 38(5):356-362. PubMed ID: 29674410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B; Zakaria el-R ; Carlsson O
    Perit Dial Int; 1996; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.
    Mistry CD; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S104-8. PubMed ID: 8728173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer.
    Khanna R
    Am J Kidney Dis; 2017 Mar; 69(3):461-472. PubMed ID: 28111028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern.
    Chung SH; Heimbürger O; Lindholm B
    Semin Dial; 2008; 21(1):7-10. PubMed ID: 18251948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
    Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of long-term peritoneal membrane function.
    Davies SJ
    Perit Dial Int; 2001; 21(2):225-30. PubMed ID: 11330573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
    Dart A; Feber J; Wong H; Filler G
    Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High peritoneal transport status is not an independent risk factor for high mortality in patients treated with automated peritoneal dialysis.
    Chang TI; Park JT; Lee DH; Lee JH; Yoo TH; Kim BS; Kang SW; Lee HY; Choi KH
    J Korean Med Sci; 2010 Sep; 25(9):1313-7. PubMed ID: 20808674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Daily Icodextrin Exchange as Initial and Solitary Therapy.
    Agar BU; Sloand JA
    Perit Dial Int; 2018; 38(2):119-124. PubMed ID: 29386305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.
    Morelle J; Sow A; Fustin CA; Fillée C; Garcia-Lopez E; Lindholm B; Goffin E; Vandemaele F; Rippe B; Öberg CM; Devuyst O
    J Am Soc Nephrol; 2018 Jul; 29(7):1875-1886. PubMed ID: 29844208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.